Article
High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with…
Therapeutics and Clinical Risk Management · 2016 · Ishikawa K, Nagai T, Sakamoto K, Ohara K, Eguro T, Ito H, Toyoshima Y, Kokaze A, Toyone T, Inagaki K
Key facts
| Title | High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis |
|---|---|
| First author | Ishikawa K, Nagai T, Sakamoto K, Ohara K, Eguro T, Ito H, Toyoshima Y, Kokaze A, Toyone T, Inagaki K |
| Journal | Therapeutics and Clinical Risk Management |
| Published | Dec 5, 2016 |
| DOI | 10.2147/TCRM.S123172 |
| Devices mentioned | BK230839, BK230840, K000042, K000155, K000270, K000576, K001014, K001015, K001468, K001846, K001906, K002148 and 197 more |
| Product codes mentioned | CDD, CDP, CDX, CDZ, CEC, CEP, CEW, CFL, CFP, CFT, CGJ, CGN and 63 more |
At a glance
- 100–999 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1